Wegovy maker Novo Nordisk sales rise 18% in second quarter
Tweet
Share
E-mail
FILE PHOTO: Boxes of Wegovy move along a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little/File Photo
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk reported second-quarter sales up 18% on Wednesday, below initial analyst expectations, after a major profit warning and new CEO announcement last week wiped some $95 billion of value from the company's stock.
(Reporting by Jacob Gronholt-Pedersen and Maggie Fick; Editing by Adam Jourdan and Terje Solsvik)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla eyes European freight market with long-delayed Semi truck
- Stocks, bonds rally after August inflation report
- US declares end of largest recorded cyclosporiasis outbreak
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
